NQO1 and cancer: The antitumor efficacy of β-lapachone has been demonstrated to be majorly associated with stimulation of NAD(P)H: quinone oxidoreductase-1 (NQO1), resulting in the prompt generation of ROS and various modulations of the pathways related to cancer progression and proliferation.